<SEC-DOCUMENT>0001144204-13-031383.txt : 20130523
<SEC-HEADER>0001144204-13-031383.hdr.sgml : 20130523
<ACCEPTANCE-DATETIME>20130523171136
ACCESSION NUMBER:		0001144204-13-031383
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20130523
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130523
DATE AS OF CHANGE:		20130523

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		13869250

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v346093_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND
EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: #7F0000 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: #7F0000 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to Section&nbsp;13 OR 15(d)
of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>The Securities Exchange
Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported)<B>
May 23, 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: #7F0000 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Medifast, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant
as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt; color: black"><B>DE</B></FONT></TD>
    <TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>001-31573</B></P></TD>
    <TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>13-3714405</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(State or
other jurisdiction of incorporation)</P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt; color: black">(Commission File Number)</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt; color: black">(IRS Employer Identification No.)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 66%; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>11445 Cronhill Drive, Owings Mills, Maryland</B></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>21117</B></P></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: black">(Address of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: black">(Zip Code)</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&rsquo;s telephone number, including
area code: &nbsp;<B> 410-581-8042</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0 0 0 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%; text-align: center">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former
address, if changed since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I> see</I> General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: #7F0000 0.75pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 5.02.</B></TD><TD><B>Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5.02(b) Resignation of Ms. Mills </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Effective May 23, 2013, Jeannette M. Mills, a member of the
Board of Directors of Medifast, Inc. (the &ldquo;Company&rdquo;), voluntarily resigned as a Director and assumed the position of
Executive Vice President for the Company&rsquo;s Take Shape for Life sales channel. A copy of the press release announcing Ms.
Mills&rsquo; appointment is attached to this Current Report as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5.02(d) Appointment of Mr. Byrnes </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Effective upon Ms. Mills&rsquo; resignation,
the Board of Directors appointed Kevin G. Byrnes to its Board of Directors and the Company&rsquo;s Audit Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Mr. Byrnes has more than 40 years of financial experience working
in the retail and commercial banking industries. He is currently Chairman of the Board of Bay Bank, with assets of approximately
$500 million and 12 branches located in the Baltimore metropolitan area. Mr. Byrnes served as President/COO and Director of Provident
Bank from 2002 to 2009. Provident Bank, acquired by M&amp;T Bank in May 2009, was reportedly the largest independent financial
institution in the Maryland and Northern Virginia marketplaces at that time, with $6.5 billion in assets, 150 branches and 1,600
employees. Prior to Provident Bank, Mr. Byrnes spent 25 years with the Chase Manhattan Bank in various executive management positions.
Mr. Byrnes began his career at Bankers Trust Co. in New York. There has been no reportable transaction since the beginning of the
last fiscal year and none is currently proposed in which the Company was or is to be a participant in which Mr. Byrnes had or has
any direct or indirect material interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A copy of the press release announcing Mr. Byrnes&rsquo; appointment
is attached to this Current Report as Exhibit 99.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5.02(e) Compensatory Arrangements of Certain Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective as of May 23, 2013, Michael C.
MacDonald, Chief Executive Officer, Margaret M. Sheetz, Chief Operating Officer and Timothy G. Robinson, Chief Financial Officer,
(each referred to, as &ldquo;Executive&rdquo;) entered into agreements with the Company which provide for certain severance and
other payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the agreements, if Executive is terminated
by the Company without Cause or resigns for Good Reason, as those terms are defined in the agreement, then, in addition to receiving
all accrued but unpaid salary and accrued vacation as of the date of termination, Executive will receive salary for one year following
termination, bonus for the calendar year of termination as if Executive had been employed through that year, and continue to be
covered by the Company&rsquo;s health, disability and other insurance benefits for a period of one year following termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The agreements also provide, notwithstanding anything to the
contrary in the Company&rsquo;s 2012 Share Incentive Plan (the &ldquo;Plan&rdquo;), that awards, if any made to Executive under
the Plan or otherwise, shall become immediately and fully vested and, to the extent applicable, exercisable as of the day immediately
prior to any &ldquo;Change in Control,&rdquo; as such term is defined in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Among other things, the agreements restrict Executive during
her/his employment and for a period of eighteen (18) months thereafter (the &ldquo;Restrictive Period&rdquo;), from soliciting
employees or health coaches to leave the employment of, or cease to maintain relationship with, the Company, hire any person away
from the Company or its affiliates, or induce any health coach, suppliers and other enumerated persons to cease relationship with
the Company or its affiliates. It further restricts Executive during the Restrictive Period from using confidential information
of the Company or its affiliates to participate in any way in any business that is a direct competitor of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><U>Exhibit No.</U></TD><TD><U>Description</U></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left">99.1</TD><TD>Press release issued by the Company on May 23, 2013</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left">99.2</TD><TD>Press release issued by the Company on May 23, 2013</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the
requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><B>Medifast, Inc.</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: May 23, 2013</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ TIMOTHY G. ROBINSON</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Timothy G. Robinson<BR>Chief Financial Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v346093_ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit 99.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><img src="logo.jpg"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Medifast, Inc. Announces New Take Shape
for Life Executive Vice President</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">OWINGS MILLS, Md., May 23, 2013 &ndash; Medifast, Inc. (NYSE:
MED), a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss products and programs,
announced today the appointment of Jeannette M. Mills to Executive Vice President, Take Shape for Life, effective June 3, 2013.
Mills has served on the Company&rsquo;s Board of Directors since 2008 and will report to Margaret Sheetz, President and Chief Operating
Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mills joins Medifast having recently served
as Vice President, Customer Operations and Chief Customer Officer at Baltimore Gas and Electric Company (BGE) where she directed
all facets of customer engagement including customer operations and the company&rsquo;s call center. Prior to that, Mills oversaw
the planning and operation of BGE&rsquo;s central Maryland natural gas distribution system. Other executive leadership positions
held by Mills during her nearly 25-year career with BGE include gas and electric new business, electric system planning, resource
management, project engineering and business transformation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Take Shape for Life continues to gain momentum and over
the last few years we have built a very strong team with direct selling experience across field operations and training that will
work directly with Jeannette,&rdquo; commented Michael C. MacDonald, Medifast&rsquo;s Chairman and Chief Executive Officer. &ldquo;In
Jeannette, we are gaining a seasoned executive with a proven track record of driving increased customer satisfaction through enhanced
planning and operations. In particular, we believe Jeannette&rsquo;s extensive relationship management and employee development
experience in a consumer-centric organization such as BGE will help our Take Shape for Life sales channel as we continue to focus
on health coach growth and client retention across the U.S.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conjunction with this appointment, Ms. Mills will no longer
serve on the Company&rsquo;s Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Medifast</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><BR>
Medifast (NYSE: MED) is the leading easy-to-use, clinically proven, portion-controlled weight-loss program. The company sells its
products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal
coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. Medifast was founded in 1980 and
is located in Owings Mills, Maryland. For more information, log onto <FONT STYLE="color: black">www.MedifastNow.com</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MED-G</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Timothy Robinson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@choosemedifast.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ICR, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Katie Turner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(646)
277-1228</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>v346093_ex99-2.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit 99.2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><img src="logo.jpg"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investor Contact: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Timothy Robinson&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ir@choosemedifast.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ICR, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Katie Turner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(646) 277-1228</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt; text-align: center"><B>Medifast, Inc. Announces Appointment
of New Independent Director </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">OWINGS MILLS, Md., May 23, 2013 &ndash;
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss
products and programs, announced today the appointment of Kevin G. Byrnes to its Board of Directors and the Company&rsquo;s Audit Committee,
effective immediately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Byrnes has more than 40 years of
financial experience working in the retail and commercial banking industries. He is currently Chairman of the Board of Bay Bank,
with assets of approximately $500 million and 12 branches located in the Baltimore metropolitan area. Mr. Byrnes served as President/COO
and Director of Provident Bank from 2002 to 2009. Provident, acquired by M&amp;T Bank in May 2009, was the largest independent
financial institution in the Maryland and Northern Virginia marketplaces at that time, with $6.5 billion in assets, 150 branches
and 1,600 employees. Prior to Provident Bank, Mr. Byrnes spent 25 years with the Chase Manhattan Bank in various executive management
positions. Mr. Byrnes began his career at Bankers Trust Co. in New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;We are pleased to announce the appointment of Kevin
to our Board and believe he brings significant financial experience given his extensive career in the banking industry,&rdquo; commented
Michael C. MacDonald, Medifast&rsquo;s Chairman and Chief Executive Officer. &ldquo;We look forward to his contributions and perspective
as we continue to focus on sales and profitability growth across our multi-channel business model with Take Shape for Life, Medifast
Direct, Medifast Weight Control Centers, and Wholesale Physicians.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Medifast</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><BR>
Medifast (NYSE: MED) is the leading easy-to-use, clinically proven, portion-controlled weight-loss program. The company sells its
products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal
coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. Medifast was founded in 1980 and
is located in Owings Mills, Maryland. For more information, log onto <FONT STYLE="color: black">www.MedifastNow.com</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MED-G</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!D`/4#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"B
MLW5?&>CZ%?PVM]JVFV=U<$"*&>Z2.20GLJD@G\*^</VO/^"OGP;_`&)/CCHG
MP_\`&]]KJZWJT,5S/+8V`GM=)AD<JDEPY=2`=K'$:NP`R0,C/7A<#B,3/V>'
M@Y.S=DKZ+<Y<5CL/AH>TKS45>UV^K/J&BHH[^&7R@LT9,Z[HQN&7&,Y'KQ4M
M<K.JX4444@"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`/FG]L__@FGX-_:>;5O$MAI&B6GQ&O(XPFIZE)J#VEQY:!$
MCFAMKJ#@J%7>#N`4<-C%?E[^TQ\"M7_9)\;/H7C?2/@_IMR4\R"Y;0O&]W8W
M:8^]'-'/)&^#P1U'<<C/[L5G^+/"UGXV\-7ND:@L[V6H1&&80W$EO+M/=9(V
M5T8=0RD$'D&OILHXFQ&$M3JMSAVO9KT;3T\K?<?.9MPY0Q=ZE-*,^]KI^J36
MOG^9_-G\;?C+IOPSM(Y[2W^#&JZC<!'CTNU^&ER!-$3S+)<:I$LP0@$`QLQ)
MQC')KA?BG^T_I7QU\;?#[6]>L(`?#.VSN[:\%Q?JME&ZO%;!VEWSVZ?O!''(
MXD56\MI714*?I?\`MU_`OQE^P5\8M)?PEK'Q1\+_``;U'2WN-8\8^'-(A\3:
M[-J_GRN7U6:<K-)`L1C1-SA`J``%MQ/S!X\^)'P'^('B_P"$M]XK^*'@SX@Z
MHOB#5Y?$?B-_A_/H\D%BUD@L1J%K%&HO"ERA8[2Q(<H69?FK]8R[,J-6G&O3
MIN2:=G&[EL]':'*GI:SES7:/RW,,OK4JDJ-2HHM-73LENM5>?,UK>ZC:R9Y?
M8?ML6_Q^^+%[<Z[I_P`/;;4+TETUSQS:ZGJMYJ4I./WMU:-YEJ<'Y$M(8HD`
MV@+@$^F^&/&%CJ.OVFE:9K?P4N-6NY!;V]GI7C#XAS7$LA.-B11,S%B>-HK8
M\`:#X@_:"O?#?@GX0>+]7^-\KZK##JUJ/A?9Z-X%L+0OF7SW95D'RG(81QOC
M)0AMF?VA_9A_90T/]EGPI-I>EZQXJ\1/+,SK>>(=5DU&XMX\G9!&S\)&BG:`
M!D@98L>:\7/L\PV`C&,8M2>T5)JR75IQ37DFM>FA[&1Y-B,=)R<DTMY.*=V^
MB:DT_-IZ=3Y0_95_X)(WVL^;J'QDBL([5D22PT_PWXU\5M(Q(!+3M=7HVX&5
M\L(3R<L.A^^-+TR#1=,MK*VC\JVM(EAB0$D(B@!1D\\`#K7S;_P5ZM+VQ_8#
M^('B/2?%7B?P=KOA"P.K:=J.B:I-83"9&`$3F-@'CDSL*MG[P(P0#7X7_LP?
M\%4_C1\.?VB_!&M^(OBU\0-6\.Z=K=I+JUG?ZY<W5M<V?G*)T>-W*L#&7ZC@
M\CFOF,%DF.X@H3Q?M5[C:Y7?>R>F^Y]+C,YP60UX83V7QI/F5MKVUVV/Z::*
M9;W"7=O'+$ZR1RJ'1E.0P(R"/;%?E+_P<@?\%`O%7P,UOP#\.?A[XNUWPMK<
MT4NNZS<:/?O:3^23Y5M$S1D-@LLS%<X^5#@\5\ODV4U<RQ<<)2=F[ZO9)*]V
M?2YQFM++\)+%U5=*VBW;;MH?J[17X2?\$-?B9\5OVV?VUUT;QM\7_BGJ7ACP
MSHT^NW6G_P#"4WR)J#))##'"Y60-LWS!R`1GR]IX)K]VZWS_`"5Y7B5A9S4I
M6N[+17VW,,BSE9GAWB80<8WLKO5VWV"BBBO#/:"BBFRLR1,RKO8`D+G&X^F:
M`'45^;?B;_@X]\*^$_CE/\/;[X3>-+/Q%9:W_8%W%<WUJBV]P)_(<$J6R`V>
M1UQ[YKVS_@M-^TI\5_V6?V-Y/$GPDL)9=9DU2*TU'4HK(7DFB6;1R,UR(V#+
M]]8TW,I5?,SC."/<?#N.A7HX>M%0=7X6VK/;6ZOW^?0\5<08*5"K7I2<U2^)
M).Z\K.W;_,^N**^"_P#@@C^UK\:OVL_@=XMU'XN+>:C:Z9J$$>@Z[<Z<EF^I
MJZR&>,;%1)%B98\,J_\`+0@DXP/M;XH_%'P_\%/A[J_BOQ5JMKHGA[0K=KJ^
MO;EML<$8[\<DDD`*`2Q(`!)`KDS#+:N$Q<L%)J4HNWNZIM]OO[;Z'7@,QI8O
M"QQD4XQDK^]HTEW_`*VU-ZBO@+X,?\%H_$?[<OQ9U/PK^SS\(9_$MMHB";4-
M?\4ZP-(L+6,DJC,D<<SY=@=JYWD*QV@!B/H?]E+X\?%WXD?$[QMX7^)WPOTS
MP2/"<=H]KK&FZT^H6&MF=6;$&^&,X0)\Q/(+`8YS6N+R7%X92==*+23:<H\R
M3LE[M[]5I:_78RPN<X7$M*@W)-M)J,N5M7;]ZUNCUO;H>[4445Y)Z@4444`%
M%!.T$D]*^:]&_P""K?PB\>?M<^&/@SX-UQ/&OB77VNOM-YI+K-INEK!;S3-O
MGSMD<^5M"Q;L;LL5Q@].'P=>NI.C!R44V[+9+5M]CGQ&+HT'%59*/,TE?JWI
M9=SZ4HHHKF.@****`"BBB@#S#]M3X/\`B#]H#]D[X@>"O"VKC0_$/B719[&Q
MO"[1JCLOW&9?F5'&48C)"N3@]#^+7_#5_@WX3>)?@QX7U#]F];/4O@AK>I:=
MXMAT.WMM4M/%5S'820R@SA6$L@8>:ZNS[%W'.`*_?2OP*_;/\<>+OV-OVT_$
M/A?P#XWT;PAHO@/QAJGB'P[:>)(D-Y875]I#37%Q'B)@]M)N,,&\L?,,8(&6
M-?H'!$_;>UPC5[)R6KCO%Q>L;]UNG;5JS5G\)QI'V/LL4G:[47HGLU):.W9Z
MIJ^B>CNOOG_@B)\*M5U"[^)GQKLM"TGX>_#CXP75O=^%_!>E7RW=K8)"'CDN
MCL^2.21L@HJJ00P*J%0#[\KP?_@F)\)=+^"W[!7POT?2;36+*&ZT2'5YX=5P
M+Q+B\'VJ82``!2))G&T`8``KWBOE<]Q7M\?5FMD[+TC[JOJVW9*[;;;/I\EP
M_L,#3@]VKOUEJ[:))7;LDDDCX>_X.'OB5_P@'_!,3Q19+.89_%>IZ?H\>.K_
M`+\7#K]#';O7XL_MQ_L7K^RM\/\`X'^(+9M0:V^*7@>VU^Y%VRDPWQ8M-&@`
M!"".2V(!R<NW/I^E?_!SSXWG\5:9\$_A3ITL;7_B?6YM1:(GE641VMN3[,US
M-_WP?2NC_P"#C']F"WC_`."=/@;5=/B61_A1J%I8B7RR66RFA%JPR.@,B6QY
M]*_1>$\=_9^'P5)NRKSFW]RC'\4C\_XJP7U^OC*J5W0A!+[W)_@V?4O_``2V
M_:<M?CK_`,$WOAYXUU6]CB?2=#^PZS<32#$4MB&@FED/;<(O-.>SBOQR^)'P
MXOO^"G4/[5/[3FLOJEMH'A".,>&XA(JAG$T20PN&!^6*S7+JN,O*I!Z@\9^S
M/_P4JO?@-_P35^+WP3MGU!=8\<:A`='FACS';V]PHCU%6?<""\44:*H!SYKG
MCO\`JC;_`+'*_LF_\&__`(T\%7%JMOKLO@:_UW7`1AC?RP&>16YY,85(LCJ(
M13>$_L+%U*RTE6JQC#RIW4I->6JB)8K^W,+3I/6-*DY3\YV<8K\'(^'_`/@U
MVNQ#^W5XOB/WIO!-QC\+VS-?JG_P43_X*>?#_P#X)Q>";.[\3_:M9\2:R&.D
M^'[%E%S>!3AI79OEBB!."[9)/"JQ!`_(+_@VM\3KH/\`P4FCM'?:=;\+ZC9H
M,_>93#/C\H2:X+_@O-XSU?Q=_P`%1OB/%JQF":+]BTZPB?.(K9;2)UVYZ*S2
M._'&9">]=>:Y!2S/B9TL0_<5-2:6[L[6^_<Y,LSVIEW#:J4%[[FXJ_2ZO?[M
MC]+/@K_P4"_;-_:]^#4GQ,^&_P`&OA;8>$9#,VG6>M:E=2:AK"Q$AC`0\2L-
MRL@9@@+*<9'-6?\`@G;_`,'`&@?M5?%JU^''Q%\,#X>>,]0N#9Z?*ERTMA>W
M(R/L[;P'@E+`A5;<&/RY#$`])^P+X<_:8\6?L3_"FT\/Z]\%_`7A./POIRZ=
M>)IU]KVJ3V_V9,22(TD$$<C9+,H+@,2,UD^"O^#=+X66_P`4+SQOXP\9>._%
M7BJ_U1M:FN+::#2;<7;3&9I$2%-R?O#D!9/EP,5\O7EDJ]O0Q<(PLVH>SYG)
M6;7O-OE?2^O?Y?345G#]A6PDY2NDY^TY5%W2^%)<RZ].WS]W_P""A?\`P5#^
M''_!.?PM:2^*9;K5_$VKQF33/#^GE3=W2`X,KECMBAW#&]NI!"AB"!\U_LC?
M\%;OVC/V_P"^U6]^%WP%\*0>&-,F,+ZKKOB&:*V5^"(O,6(>9)M()$:';D9Q
MD9_*G_@KW\6-5^,'_!2'XMWNJSRRG2-?N-#M$9B5@M[-C;QJH_A!$98@?Q.Q
M[FOZ#_\`@G%\)](^"O["?PIT+1($AM1X:LKV5E4`SW%Q"L\TK8ZEI)&.?>M\
MSR?`Y/E5&M4IJI6JVUDWRQTN[)-7M=+7U\C#+<WQF;9I5HTZCIT:71)7>ME=
MM/?5Z>GF?SQ_'74/$.J_\%2/$-QXLL].T_Q-+\1V.IVNGS--:V]Q_:`WI&[`
M%T!X#$`D#.!TK][?^"I7[?FL?\$Z/@CI?CBS\#V_C73;W4UTJ[5]6-BUD\D;
MO&^/)DWHWELIZ$$KUSQ^%?[77_*87QU_V52X_P#3G7ZV?\'+'_*-L?\`8U:?
M_P"@3U[W$-"EB<7EE&M%.,E9K5*S4>SOIZGB9!7JX?"9E5HRM*+NGH]4Y=U;
M\#OO^"1?_!4#4?\`@IAX=\<WU]X.L?"">$+FSMX8K;4&N_/$R2L228TQM\L8
MP.<^U?(/_!S9^U#X\TO0?#/PMFT2RT3P;K]T^J"^35%N+O6OLNT!7A4#R8E>
M56`8L790?EV$'6_X-2_^2=_&C_L(Z5_Z*NJ^:O\`@Y9^,/\`PG__``4&M_#D
M-SYMMX&\.VEB\8Z17$Y>Y<_4QRP@_P"[7#E>4X>EQ9/#T::Y*:YDM7;W5JM=
M^9];_D=F:9K7J\*PKUIOGJ.S>BO[ST>G9=+?F?1O_!O=X=^-'PQ_9?N=7\'_
M``[\%:UX9\<^(VFFUK5/$<EA>110[+=@(%MY/,2-EF9?G!)9AQUK[A\8?MT>
M+?$/QW\5_#SX5_!_7/'6H^"I8K76-<U'58-%T"TN)($F6)9V$LDKJLB;E2(L
MN>1C!KH_^":GPG/P0_8&^$GAMT\NXM/#5I<7*;-A6>=/M$H(]1)*PYYKPS]K
M'_@MO\,/V8_BP_PV\!^'K_XH_$>]U'[')I6@>7#;#4)'V>3+<8.Z<OM5@B.0
M<AB&!%?.8RI/-,TKRHX=5'=VUDE9.RE)\RV2[Q6OR/H<)".6991C6KNFK*^B
M;NU=QBK/J^TGI\SC/VX?^"H/[3'[`7A_3O$7C;X)_#ZZ\+:E=BS6_P!(\27%
MW';S%2RQ2%HD968*V&,>T[2,YP#]`_\`!,;_`(*5>'O^"E/PAU+7=,TFY\.Z
M]X=N4M-9TF6;SQ;LZEHY(Y0JAXW"OC(#`HP(Z$_$?_!=+Q;\?KW_`()]Z?>?
M%&'X7^&-)UWQ'9P'P]HHNKW4H9/+FF0/>.XB)01$,L<1!)X?`YH?\&J5M]N\
M+_':`NZ":31D+*<%<I?C(]Z]/%9-@Y\/3Q_)&-6$DKP;::YDM;MI[].RU/-P
MV<8N&?PP//*5.<;VFDFGRMZ62:VZ]]CVS]H3_@OOIEI^T]8?![X*^#H?B-XJ
MO]8CT(:G?:F+#2OM;2>44C8*S2HK8!DRJ\';N&"?HK5?B'^T[X!\)C6+[X??
M"GQK-!&9;G1O#_B.\L;TX!)6![FW,4K#IAC'N]17X=?M3_\`!&_]H3]D'XD7
MESIWA/Q%XJT?3;HW6F>)/#44EV2J/NCF98LS02+@$[@-K#AF`#5T'P6_X+T?
MM._LY7JZ;K'B"+Q=!:.HDL?%>G^;<*!P5,J^7/DCNS'GGUKUJ_"&%KT*<\F=
M.HDO>YG*\GZIZ>GNV[GE4>+<30KU(9PITVW[O*E:*]&M?76_8_<3XS?'GQNO
M[&#^//!/@9KGQ-J'A\:I_8NN7HT]]'+6IE=9\J2SQ'Y3&`-S#&Y1R/Y_O^".
M^N>-M)_X*+^!+[P#HVB^(O%:_P!H-;V&JWS6-I<*;&X$NZ958H1&7884Y8`8
MYK]I?V./^"CVF?\`!27]@[XA^)(M'?P]X@T#2[W3]9T[S?.BCE-F[I+$^`3&
MXS@,`058<X#'\A?^"`/_`"E8^&W_`%RU3_TVW51PU0GA,OS*C6I*,H)W3N_L
MR:3=]5V:M>^Y?$E>.*Q^75:51N,FK-67VHIM*VC[WO:VQ_0+^SWXB^(WB;PA
M=7'Q,\,^&_"NM+=LEO9Z+J\FJ0O;A$(D:1XHL.7+C:`0`H.><#O***_*JLU.
M3DHI7Z*]E][;_$_4*<7&*BVW;J[7_!)?@%%%%9EA1110`5^'7_!>;X<RVW_!
M2*R!B\Z3QQIMFME%J%E]MEO)/LUQ:>58ML98EWB)51_NW,PE.%RP_<6OSP_X
M*N?L(>*/VC?V\/V?O$'A_P`.:GJWAZ[ODTWQC=P7*I%:6=O*9E+EE)BS#->#
M</ODJHPVPGZO@[&PPV8.=1V3C)7?DK]?3]/,^8XNP<\3@%"FKM2B]/6W3U_4
M^_\`PCHO_"-^$]+TX2WLXL+2*V$EW-YUQ)L0+ND?^-SC);N<FH?'7CS2/AEX
M4O==U_4(-+TG3T#W%S,2$C!(`Z<DDD``<DD"M:BOE^9.5Y:]SZ5IJ-HZ'\^_
M[9W[66H?M5?\%9O"/Q.NO"7C27X8^"-<TJWL%?1+D2OIMK=+-+-Y>S=F1S-(
M%(W;653R,5^QW[2VE>'?V_OV$OB+H/A+48-?M_$FAW5K9/""I^V+'YL"E7`*
MD2B(X8`U[U17T>9<00Q"P_L*7LW024?>NM&GK[JUNM[GSV79#/#NO[:KSJLV
MY>[;=6TU>EGM8_G\_P""'G_!*WQ)^T9^T?IGCSQKX>OM-^'?@2\6\<:C;O"-
M9OHSNBMXU8#>B.%>0\KA0AY?C]6_^"PO[0&B?"C]AOXA^'YVN+[Q-XTT"ZTC
M2-*M+>2XN;M[A3"7"HIVH@9G+-@?)C.2`?JBBKS3B>IF&80QN(A[L+6BG;9W
MWL]WN[>6A.6<-T\!@)X.A/WIWO)J^ZMM=;+97\S^9[_@E9XCUS]D[]OGX=^.
M/$7AOQ39^'].O);;4K@:1<N+>"XMY;=I"%0L0GFAB`"<*<"OT:_X+%?\$JV_
MX*+V6F_&_P"!][INN^(S9"TU"P698DU^*(E4DBD<A5GC&8RKX#*JC(*8;]1Z
M*[\?QM6K8ZGF.'I\E2*Y=[IQNW9JR[]_Q.'`\&TJ."GE]>ISTY/FVLU*R5T[
MOMV/Q_\`^"8O_!2GQ]_P3^^&T'P=^._PD^*L-AH$CC1-4M-!GGFM8&;>8)$;
M;OC5F)1XV;`8+MP`:^T/A%_P4>\0?M3?'?P[X:^'OPD^(>G^#WG>;7O&'BK1
MI=,L;>W2)W$5LC<R2R.$0%BNT,3M;M]845Y&89QA,54GB/JRC.5[^\^6[^UR
MVWZ[VONF>I@<IQ6&IPH?6&X1M;W5S673FOMTVO;9GXG_`/!;[_@C3\1-7_:,
MUKXL_"WP]?\`C'1/&,@N]6TS38_-OM-O-H$CK"OS212%=^4#,'9P0!M)^@?^
M"6__``5!U/X5?LQ:-\/_`(S_``W^+>A:YX&M$TRQU"'P;J-Y%J=I&-L*,$B9
MXY40!"&&TA5.X$D#]+Z*ZZW%+Q6`A@,=24U"W+)/EDK:=FGIIM^.IS4N&EAL
M=/'8*HX.=^:+5XN^O=-:Z[_AH?S*_&;P3\0_BC^W=XA^*$/PH^)EIHNL^-9/
M$4<,GAN[,\=N]X9E5@(\;]G8'&:_5_\`X.&[R[^*O[`'AS1_"VB>(_$FI>*-
M?L]0L[?3=)N+B5;=()7:6150M&!YD8PX!RX&.#C]"Z*Z<9Q@Z^(PV(]BE[#9
M<SUVM?3I8Y\)PDJ&'Q-#VS?M]WRK3>]M?,_)_P#X-B?"NO?"BQ^+7A_Q3X:\
M3^&]1U233M0LQJFD7%I'=11B>.0H\B!25:1,KG.&SC`./SY^,=O=?\%`O^"O
MFMV6F[]0B\=?$`Z?;R1KO'V!+@0K+Q_"EM'O)_NJ37]!/[>'[0`_9G_90\9^
M*85GGUI+%K'0K2",RW%]J=Q^YM(8T&6=FF=/E4$X#''%?'7_``0V_P""/EY^
MR):GXK?$NV5?B1K-J8M-TQB'/AZVD`WF0_\`/U(/E;'W%)7.68#V\NXCIP>,
MSRK'EG42A"-[WDEK;R5HM_YV/%S#A^I-83):4N:%-N4Y6M9-Z7\W>27_``Y^
MA?C'1KR]\!:KIVC3)87\VGS6]C+C"VTIC*QM@=E;!X]*_F;^!.F?$K_@G/\`
MMW^&/$GBSX<^(K[7?!6L&XNM,N;20M?J59':*7:RL2KEDD7<-VUN:_I[HKY;
MA_B1Y9"M2E252-56:O9]5NK]&_\`,^FS[AY9C.E5C4<)4W=.UUT>VG9'Y`?\
M%==/^.G_``4K_92LO&ND?"SQ-X*\!>"+R*]MM`U6W,GB3Q#+,/*:[%K$&,4,
M"-@`_,PED;HHPO\`P;5^'O%7P9?XSZ#KWA/Q3X>UG6K&QU#23J>CW%M#=&W%
MRK*K2*JE@TT1VYR02>QQ^OU%;3XJ;RR>5JBE!NZLWIJGK>]]5JV^O16,8\,)
M9E#,W6;FE9W2UT:Z6MH]$NW5W/D;X'?\%9O"Z>`;&#XXZ1XB^"?CNU@1=4LO
M$6BW=K83R!1NFMKDQF)HF.2`SAAR"#C<?A__`(+5_M">"/\`@IE'X,\$_`7P
MEJOQ1\;6&IF:X\1Z1H<QCM[<1.IM!.R*75F=78G]VGE`[LDX_9AE#J58!@>H
M(R#200);1A(T6-1T50`!^5<V7YSA<'BEC:-%J:NTN?W4WY<MVO+F]6=./RC$
MXO#/!UJR<79-\GO.WGS63\^7T1\3_P#!*#_@F9K'[&/[#?B?PIXEN;5?''Q&
M2>XU5(W$L&F%[<PPV^]?O[`2S,,C<[!20`3^.7[+J_$/_@EE_P`%`/#/B+QA
M\/\`Q.+SP;?RPW]@EF^^\MY89()&@<C9)F.1F1@=K8'('-?TST5VY?QC6HSQ
M,L33515_B5^7HUH]=+.WW:G%C^$J56&'CAJCINA\+MS=4]5IK=7^_0^9?A=_
MP4OT_P"*'PI\7?$`_#?XC^&?!'ABVM3;7FOZ<EC=:]<SR>6L5K"7(9%8HIE9
MU7=(.P+#U?\`9C_:/TG]J3X:'Q+I%EJ.G11W3V<MO>HJRHZJC@_*2"K1R1N#
MP<.,@'(KM?$_AC3O&GAZ\TG6+&TU/3-1B:"ZM+J)98;B-A@JRMP0?0U3\`_#
MK0_A9X;CT?P[I5GH^FQR/*(+:,(I=V+.[=V9F))8Y))Y-?/5ZV$G"7LZ;C*^
MFMTE;K?=WU_R/H*-+%0G'VE12C;72S;OTMLK:?YFU1117GG<%%%%`!1110`4
M45\V?\%:(A<?L4:K"]A=:O%<>(?#L,NFV\PAEU.-];LE>V5RR`&524R64?-R
M0,FNG!T/;UX4+VYFE?M=V\OS1SXO$>PH3K6ORINW>ROY_DSZ3HKX,\&Q^,/V
M(-"^)?Q-T'X6:GX"\`VNDZ99Z=X!U3Q/'=OJFJ/J`CDOE,<MQ%9#RIDCVJY\
MPJ&91M!/LS?M#_&?6_'4W@;1?!/P_F\9Z!H\6N^(9[KQ!<QZ19K=3W"65G`Z
MVQFEG=+:1GD,:1IMXW[@!W5LIFFY4I*4>]XKHF[^\UI=+1M7:5[Z'%2S6+25
M6+4NUI/JTK:)ZV;U2=DWMJ?1M%?+'A#_`(*<Z;>:?;:UXD\/2>&_#M]X-U;Q
M##+)=B:==0T>ZDM]6TTX4(S1D(T3J?WJEB%&*XKXE?\`!5GQ!X`UAM$N/"_A
M33?%/AKP_I^K^)=)U/4[U9I+RZMOM7]F61@M)5:1(BH,LQ12[J`N`S`AD6-G
M)PC#5>:[V?7H]'V>X3SO!QBIN>C\GVNNG5:KNMC[<HKY+\6_M_>/=6N/&M]X
M)^'VBWF@>`O".F>-;^37M6FT^]N+:[LY;K[&D*PN$N52&3)=MBG:#U)7Z@\$
M>*X/'G@O1]<M5D2UUJRAOH5D&'5)8U=0??#"N3$X&M0BI55:_FGT3UMMHT]3
MJP^.HUY.--WMY-=6M+[ZJVAJ45\G^)?BOXY^'?\`P4"^)</A'X;ZQ\1X[GPE
MX;:=+77;+3H]-(FU;&5NI$#&3U3.-GS=J\F^$O[==]^SG\.?&MUK.B0Z9XO\
M>?&/7-.M]/UK4GDLM!\NUAGF-Q/;),62-$X6%6W,Z@%1N9>Z&25JD;TVF[1:
M5U?WE?57NK=VM3BGG5&$K5$TKR3=G;1VT=K._9/0_0FH9]2M[6[@MY;B&.>Z
M+"&-G"O-M&6V@\G`Y..@KY*T3_@I1J'B3X`W^OQV7@G2_$&E^)QX:>74M0OT
MTK5`8!.MS8*EHUW=%U8+Y"PAU99,MMC+'CM._:9U3]JCXN?L\^*--T73=/\`
M%>GZOXUT46EU-<)8/?6NGR1;][PK<)!(55OGA610V"F0<D<CQ*YG57*ES:Z;
MJ+DOOMOT'/.\/HJ;NWRZ:[.2B_NOMU/N>XOH;2:&.6:*.2Y<I$KN%:5@I;:H
M/4X!.!V!-2U^>W@SXS?&'XG_``:_9N\4ZSIWA3Q+XQU#X@7L.DLNH26\,R?V
M;K4+S79\@>6L2J3B)79U0#AFQ7M?@3]O776\3Z!I7B_POI>DG_A.[[X<>(+V
MRU!Y[6QU-;5+JPEA+1J6M[E'5#OVM'*Z+ALYI8C)*].ZBU)J][-=&UIU:T[;
MZ;A0SJC42<DXIVM=/JD]>B>O?;78^D=2\-Z?K.H6-W>65K=76F.TMI++$KO:
MNR[2Z$_=8J2,CG!(Z$U=KQKX8^+&_;G_`&4->N-3TXZ)H/CZ'5=-TLQ2N9[C
M2G>6WMKPY"E'FB`F4#.T2)R3S7Q7XJ^,OC;XU_!7X9W,%UJ$?BC]FWPH_C;Q
M;$MRP-[JVEZ@-.>UGV9SYT-CK#;3G.Y#C!HPN43K2<)2Y7%\KZVNG;KU:MY-
MH,5FT*,5.,>927,K=;-7Z=$[^:3['Z<T5\#^+?VX[+X=?'?QS\2K&:PU:/Q9
MKEC\-?",M_>RQZ1!;V%C)J-]?.T$<KE#-<R)A$+.T,8^499>V\$_MC6?[2+?
M#B;7?"4$VJZ9\3QX?CO+'4[V'31-_9%Y=QZA:EXX7N(S&#$T4R`*[/G=L5BZ
MF1XB$54:?+:]].UVK-K9Z/S3T%#.\/*3II^]>UM>]D[I=5JO*VI]A5%9ZA!J
M*R-;SQ3B*1HG,;APCJ<,IQT8'@CJ#7R-_P`/`/B7=_"GPU\4;;X<^&3\,_&>
MOZ;I6F>9K\JZU;6E[J$-G#?W$0@\K#^9N\E)"R[X\L?GV\E\`/VA_&OP#M_'
MNJ-X2T.[^&W_``NW5]"OKTZJZ:L9+_7#;+<PP"(QF**>XB5E:0.P$C#&%#"R
M3$<DF[73LE=:OJM]UIIU&\ZH<Z2O9J][/;H]MGKKTL?==%?/'[%_Q0^*_P`0
M_BE\6[3QTOA%]#\->*9M*LCIMW/)<6CBRL)E@4/!&'@VS.Y=FW^8[+C:%-7/
M@)<RR?MX?M!1-+*\<5IX8*(S,53-I=9P"<#..<=?PKEJ8"4'4C*2]R*EIK>[
MBK?^3?@=,,?&:@XQ?O2<==+64G?_`,E/>Z*^6_'O[<WCG2-!^(GCS0?`N@ZE
M\+?A9J-[I^K376M20:UJ2V#%=0N+6$0M$%A99`J22!I?);!0,N7Z5^WYK&J?
MM4W_`((DT#P]I>E03/%IMOJFI3V6M^)(19BXCO-/C>`6MS'([>4(EG\P;69@
MN"M6LHQ3BY)+1-O5:6M=/71JZT_X)#S;#)J+;U:2T>M[VMIMH]?^`?4-%?.W
M[#/[9NM?M47VM0:]IWA+0;[3K6WNI-%M=3NCK>BO(6WVM_9W-O"Z/'A1YR;H
MG;<%)VY/T37)BL+4P]1TJJLT=6&Q5/$4U5I.Z84445SFX4444`%%%%`!7*_&
M7X.:-\=O!::!KZW36$>HV.J`6\QB?SK.ZBNH?F';S84R.XR.]=515PJ2A)3@
M[-:HF<(SBX25T]SE_C-\(=(^._PXO_"NO"Z;2M2>!YOL\IBES#/'.F&'3YXU
MSZC(KD?C1^R'H7QB\>0^*H=>\9>#/%"Z=_9%QJGAC5387%]9;VD6";*LKJCL
M[(VT.A=]K#<<^K45K2Q56E;DDU:_XVO]]E]QE5PU*I?GC>]OPO;[KO[SQ;QG
M_P`$^_A;XY^%?@+P7=^'VB\/_#?4X-6T6"&=E998BQ997.6E28NQE#D^:6)8
MD\U;^+'[&>@?%'X@WOB>W\1^._!VKZS:16&L2>&-;?31K4,6[RA.%!^=`[JL
ML>R4*Q`?&,>O45HLPQ*:?.^O6^[N_O>OKKN9O`X=JW(NG3LK+[EIZ:'G-Y^R
MUX6O;GQ_*_\`:A;XE:);Z!K&Z\9R;:"">!-C-EE?9<29<DDG!/2HOA1\$M7^
M'?Q6UC4IO$%Q<^%(-!TKP]X<T59)/+TZ*U64S3R@G8\\KR(N\`$)"@]:]+HJ
M'BZKBXMW326OE;[M$EZ:%_5:2DI)6:=]/._ZMOUU.9T3X3:3X?\`BSX@\:6_
MVK^VO$UA8Z;>;I<P^5:-<-#M7'RMFZER>_R^E>?:_P#L(^"-<T;5((YO$6EZ
ME?\`BRX\:V^L6&HM!J6DZG/&(Y9+:4#Y$:/=&8V#(R.P8$'CV>BB&+K0?-&3
M3T_#1?AH.>%HS7+**:U_'5_CJ>)ZQ^PMH&M^&-`MKCQ=\1Y/$'AG5Y];L/$\
MFO--K,-Q/`UO,`\BM$L30N8_*6,1@8*JIYJQ\,_V%_!'PIUWPUJ>G2>(;B^\
M+:OJVN6DU]J;W,DUWJ<92[DF9OFD+Y9N3PS$U[)16CS#$N+@YNSO^-[_`"U>
MGF^YFL!AU)24%=6_"UOGHM?)=CQKX7_L.^%/A,=#CL-4\5W=AX7U^?Q%HEC>
MZB)K?2)IH;N&2&$;`WDE;R8[69B#M.>,5SW[37["=A\5OV>?B=X+\.BW@O/B
MMKT6N:E=ZE=28T^YS9QO<V^Q&*R1Q6BM&O`,@&6`8D?0U%..98E556YVY)I_
M<[_GKZDSR_#NDZ/*E%IK[U;\M/0SO"'A2P\">$]+T/2K=+33-&M(K&S@0`)#
M#$@1$`'0!5`_"N(^&/[*'@OX1^)_B-JVCZ?(ES\4]0.I:^LLF^.>4QE&"KCY
M5;<[$<Y:1SWKTBBN>.(J14DI/WM_/6^OSU.B5&FW%N*]W;RTMI\M#PSP]_P3
MP^'?@W]G?PI\-M#77M#TWP-?-JF@ZI8:@T.KZ9>.TI>X2X`^9F6>9&#JRLDA
M5E(KHM`_9,T+2M-\+17^M^,O$E[X3\0-XFM=0UK69+RZFO#;36WSD_*(A%.X
M$4:H@(!`SG/J-%;3S#$ROS3;NVWKU>_WW=S&.!P\;<L$K))>BV^ZRL?'?C/_
M`()F77B+0O#%KI%[<^&K+3?&-CXBE\.KXMO+WP_HL<&H)=RO8V[6Z;I9`CJL
M4FV&(SNRC*KGW&[_`&//!U]\/-7\,2+JITS6O%O_``FMP!=D2?VA_:*:CE6Q
MQ']HC7Y/[N1GO7J=%:ULUQ-1).3T=UZ][[_UW,Z668:FVU%:JS].UMOZ['G_
M`(%_9STKX<?&7Q5XSTO5_$D3^,I1=:CH[WH?26NO*@A-TD)7<LQCMXU)#[3@
MG;DYKE?B+^P_I'COXM:WXTLO&WQ+\'ZQXBAM8=27P[K@LK>[%LC)"S(8V^95
M9AG/.:]JHK"..KQESJ6MDODK67X+[C:>#HRCR..E[_-WN_Q?WG@GBG_@G5X(
M\7:QJS7&L>.(M"\2W27WB#PY;ZV\>C^(;@!`\MS"%R3-L7S0C(LN#O5LMG5\
M1?L/>&?%_P`4K?Q+J^O^/-3M;#4SK5CH%QKTK:1IU[Y+0K/!%]^(HKL419`B
M,Q95!YKV:BM/[2Q7\[VM_7R25][*Q']GX;^1;W^[_@MNVUSR?X&?L?:%\#?'
M=YXH77_&OBWQ#<Z7'HD6H>)=7;4)[*PCD,HMXV*K\I<[F9]TC%1ECBO6***Y
MJU>I5ESU'=F]&C"E'DIJR"BBBLC4****`"BBB@`HHHH`****`"BBB@`HHHH`
J****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
